. 2007 Oct 26;99(1):145–151. doi: 10.1111/j.1349-7006.2007.00639.x

Table 1.

Characteristics of all randomized patients in the Japan Clinical Oncology Group study, JCOG 9208

Treatment arm		Standard‐dose	High‐dose
No. of enrolled patients		48	49
Median age in years (range)		47 (27–55)	46 (29–55)
Menopause	Pre/post	34/14	38/11
PS	0/1	41/7	46/3
No. of positive axillary nodes	Median (range)	18 (10–46)	16 (10–49)
	10–19	28	28
	20–	20	21
Stage	I	2	2
	IIA	8	12
	IIB	18	16
	IIIA	10	9
	IIIB	10	9
	IV	0	1 ^†
ER	+/–/unknown	29/19/0	25/22/2
PgR	+/–/unknown	25/22/1	22/24/3

^{^†}

Ineligible. ER, estrogen receptor; No., number; PgR, progesterone receptor; PS, performance status (0 or 1 according to the Eastern Cooperative Oncology Group criteria⁽ ²⁸ ⁾).